Sanchem Life Science

Sanchem Life Science is committed to delivering high-quality pharmaceutical and healthcare products with a focus on innovation, quality, and customer satisfaction. We strive to provide reliable solutions that meet global healthcare standards.

Intrinsicly evisculate emerging cutting edge scenarios redefine future-proof e-markets demand line

Gallery Posts

delivery Trusted pharmaceutical solutions for every stage of life

customer-service Need Help? +91 9811494850

Ampozit-625 LB (Tablets)

Ampozit-625 LB (Tablets)

Ampozit-625 LB is a tablet formulation from Sanchem likely combining Amoxicillin and Clavulanic acid with an added Lactic acid bacillus component (indicated by the


Description

Understanding Ampozit-625 LB
 Ampozit-625 LB, developed by Sanchem, is presumed to be an Amoxicillin-Clavulanate combination with added Lactobacillus, used to treat a broad range of bacterial infections while helping offset gastrointestinal side effects common with antibiotic therapy. This combination approach reflects a well-established convention in antibiotic formulations, where a probiotic component is added to support gut health during a course of treatment.

How It Works
 Amoxicillin is a penicillin-class antibiotic that inhibits bacterial cell wall synthesis, leading to bacterial cell death. Clavulanic acid inhibits beta-lactamase enzymes that some bacteria produce to break down amoxicillin, restoring its effectiveness against strains that would otherwise be resistant. The Lactic acid bacillus component supports healthy gut flora, which can be disrupted during antibiotic treatment, potentially reducing the incidence of antibiotic-associated diarrhea.

Common Areas of Use
 Respiratory tract infections (sinusitis, bronchitis, pneumonia), urinary tract infections, skin and soft tissue infections, dental infections, and other bacterial infections caused by susceptible organisms, as determined by a physician.

Dosage and Administration
 Dosage and duration depend on infection severity, patient age and weight, and renal function. Typically taken with food to reduce gastrointestinal upset. The full course should be completed as prescribed, even if symptoms resolve early.

Safety Information
 Ampozit-625 LB is contraindicated in patients with known penicillin or cephalosporin allergy, or a history of amoxicillin-clavulanate–associated liver dysfunction. Caution is advised in patients with renal impairment. Patients should disclose all allergies, current medications, and pregnancy or breastfeeding status before starting treatment.

Quality You Can Trust
 Every batch of Ampozit-625 LB is manufactured in a GMP-compliant facility, with rigorous testing at each stage to ensure consistent potency, purity, and safety.

Why Choose Sanchem's Ampozit-625 LB
 Ampozit-625 LB reflects Sanchem's commitment to providing effective, well-tolerated antimicrobial therapies supported by rigorous quality standards.

A Note for Healthcare Professionals
 Sanchem welcomes healthcare providers to reach out for susceptibility data, dosing strengths, and full prescribing information for Ampozit-625 LB.